Koyfin Home > Directory > Health Care > Anika Therapeutics > Long-Term Investments

Anika Therapeutics Long-Term Investments Chart (ANIK)

Anika Therapeutics annual/quarterly Long-Term Investments from 2020 to 2020.
Other Cash Flow Metrics:
  • Anika Therapeutics Cash Flow from Operations for the quarter ending September 09, 2018 was $11m a 35.61% increase of 4m year over year
  • Anika Therapeutics Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $9m a 40.85% increase of 4m year over year
  • Anika Therapeutics Total Revenue for the quarter ending December 12, 2018 was $27m a 21.12% increase of 6m year over year
View Chart On Koyfin